The Accelerated Cure Project (ACP) is a non-profit organization dedicated to advancing research efforts for the improvement of diagnosis and treatment, and finding a cure for multiple sclerosis (MS). ACP collaborates with all MS stakeholders, including patients, caregivers, researchers, clinicians, and funders, to develop centralized resources for scientists worldwide. Established in 2001, ACP offers resources like the ACP Repository and the iConquerMS network to support and expedite MS research.
2001
04-3555864
$2.713 million
This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.
iConquerMS facilitates patient-driven research where individuals affected by MS take active roles in proposing, planning, and conducting studies alongside researchers, ensuring research focuses on topics most relevant to the MS community.
ACP's commitment to inclusive research ensures minority representation by supporting the MS Minority Research Engagement Partnership Network and the Research Inclusion Diversity and Equity Council, eliminating barriers to participation for historically marginalized populations.
Collaborative efforts through the ACP Repository have led to pioneering research studies that include genetic analyses and clinical trials, enhancing our understanding of MS and fostering developments in diagnosis and treatment methods.
ACP Repository Establishment
The ACP Repository, comprising highly characterized biosamples and data from over 3,200 individuals, provides a crucial resource for MS researchers globally, facilitating numerous studies to understand and combat MS.
iConquerMS Network Launch
iConquerMS is a pioneering patient-powered research network with over 8,500 members sharing their insights and health information to shape and accelerate MS research.
05/2024
Explore how iConquerMS harnesses participant experiences to drive MS research forward as part of its 10th anniversary celebration.
2023
Engage with researchers and members of the iConquerMS community to prioritize research questions and develop studies dedicated to solving MS.
2023
Discuss groundbreaking MS research and discoveries, providing insights from leading experts in the field through the RealTalk MS podcast.
Overall Score
68
68
/100
Program Expense Ratio
86.38%
18
/20
Program Revenue Growth
45.86%
18
/20
Leverage Ratio
0.1014
18
/20
Working Capital Ratio
1.377
12
/20
Fundraising Efficiency
0
2
/20
Fiscal Year:2022
Source:Source: Self-reported by organization
Category | Amount | Percentage |
---|---|---|
Contributions, Gifts, and Grants | 1.539M | 67.62% |
Program Services | 724.9K | 31.85% |
Investment Income | 18 | 0.00% |
Sales of Non-Inventory Assets | -117 | -0.01% |
Other Notable Sources | 0 | 0.00% |
Total Revenue | 2.276M | 100.00% |
Health Associations
Nerve/Muscle/Bone HealthHealth Associations
Nerve/Muscle/Bone HealthHealth Associations
Nerve/Muscle/Bone HealthHealth Associations
Nerve/Muscle/Bone HealthHealth Associations
Nerve/Muscle/Bone Health